Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.

Pharmaceutical

Sparrow Pharmaceuticals

Sparrow Pharmaceuticals' headquarters in Portland, OR, United States

Robert Jacks

Sarah H.

Jamie MacPherson

Jeff Drajesk

Frank Czerwiec

David Katz

Peter A. Thompson

Sparrow Pharmaceuticals' Leadership Team includes Robert Jacks and 4 others.

About

People (5)

David Katz

Frank Czerwiec

Jamie MacPherson

Jeff Drajesk

Robert Jacks

Jobs